# Chidamide With R-CHOP Regimen for DLBCL Patients

> **NCT03201471** · PHASE2 · UNKNOWN · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 39 (estimated)

## Conditions studied

- Diffuse Large B Cell Lymphoma

## Interventions

- **DRUG:** Chidamide + R-CHOP regimen

## Key facts

- **NCT ID:** NCT03201471
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-20
- **Primary completion:** 2019-12-30
- **Final completion:** 2020-02-05
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2018-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03201471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03201471, "Chidamide With R-CHOP Regimen for DLBCL Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03201471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*